FDA OKs Pancreatic Islet Cell Therapy for Type 1 Diabetes
Approval of Lantidra, a beta cell therapy derived from donor pancreatic islets, came despite transplant surgeons' concerns about FDA regulating these cells as biologics rather than transplanted organs.
Medscape Medical News
source https://www.medscape.com/viewarticle/993854?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/993854?src=rss
Comments
Post a Comment